NCT00416819View on ClinicalTrials.gov

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

February 29, 2012

Conditions
Brain and Central Nervous System TumorsLymphoma
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

rituximab

DRUG

cytarabine

DRUG

etoposide phosphate

DRUG

leucovorin calcium

DRUG

methotrexate

DRUG

temozolomide

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00416819 - Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma | Biotech Hunter | Biotech Hunter